Cas 544675-02-7,5-benzyl-6-propyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

544675-02-7

Post Buying Request

Basic information

Product Name: 5-benzyl-6-propyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
Synonyms: 5-benzyl-6-propyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
CAS NO:544675-02-7
Molecular Formula:
Molecular Weight: 268.318
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-benzyl-6-propyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(CAS DataBase Reference)
NIST Chemistry Reference: 5-benzyl-6-propyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(544675-02-7)
EPA Substance Registry System: 5-benzyl-6-propyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(544675-02-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 544675-02-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

544675-02-7 Suppliers

Recommended suppliers

544675-02-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 544675-02-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,4,6,7 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 544675-02:
(8*5)+(7*4)+(6*4)+(5*6)+(4*7)+(3*5)+(2*0)+(1*2)=167
167 % 10 = 7
So 544675-02-7 is a valid CAS Registry Number.

544675-02-7Upstream product

544675-02-7Downstream Products

544675-03-8 5-benzyl-3-bromo-6-(1-bromopropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

544675-02-7Relevant academic research and scientific papers

Mitotic kinesin inhibitors

-

Page/Page column 29-30, (2008/06/13)

The present invention relates to azolopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositi

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 544675-02-7